Skip to main content

Peer Review reports

From: Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study

Original Submission
23 Sep 2023 Submitted Original manuscript
19 Nov 2023 Reviewed Reviewer Report
29 Nov 2023 Reviewed Reviewer Report
12 Dec 2023 Reviewed Reviewer Report - Bernard Ngara
30 Jan 2024 Author responded Author comments - Nivriti Hurbans
16 Feb 2024 Author responded Author comments - Nivriti Hurbans
Resubmission - Version 2
30 Jan 2024 Submitted Manuscript version 2
21 Feb 2024 Author responded Author comments - Nivriti Hurbans
Resubmission - Version 3
21 Feb 2024 Submitted Manuscript version 3
24 Feb 2024 Reviewed Reviewer Report
6 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
6 Mar 2024 Editorially accepted
21 Mar 2024 Article published 10.1186/s12879-024-09202-6

You can find further information about peer review here.

Back to article page